Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma. Geng B, Dixon AE, Ko J, Janampally P, et al. Ann Allergy Asthma Immunol 2022 Jan 28. pii: S1081-1206(22)00045.

Read + Share

Amedeo Smart

Independent Medical Education

Geng B, Dixon AE, Ko J, Janampally P, et al. Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol 2022 Jan 28. pii: S1081-1206(22)00045.
PMID: 35101644